603259 药明康德
2023/122022/122021/122020/122019/12

盈利能力分析
净资产收益率 ROE (%)18.89020.71814.36111.88710.597
总资产报酬率 ROA (%)13.88714.71210.0527.8397.146
投入资产回报率 ROIC (%)16.07417.20911.6869.0678.424

边际利润分析
销售毛利率 (%)41.17937.29636.28537.99238.951
营业利润率 (%)29.43027.06726.36320.49818.186
息税前利润/营业总收入 (%)28.49226.35126.63323.52018.341
净利润/营业总收入 (%)24.04622.62122.42518.06014.849

收益指标分析
经营活动净收益/利润总额(%)98.31289.97571.94477.377104.859
价值变动净收益/利润总额(%)1.6579.02220.99319.544-9.059
营业外收支净额/利润总额(%)-0.341-0.318-0.368-0.597-0.169

偿债能力分析
流动比率 (X)2.0621.6551.6932.9111.909
速动比率 (X)1.7411.2641.2382.5721.646
资产负债率 (%)24.64027.46029.69529.32040.458
带息债务/全部投入资本 (%)9.43711.85911.73010.26319.926
股东权益/带息债务 (%)914.681705.652701.827782.145350.139
股东权益/负债合计 (%)303.673262.277235.136239.406146.349
利息保障倍数 (X)-33.994-41.82272.5447.48298.533

营运能力分析
应收账款周转天数 (天)61.90648.44765.11071.86068.956
存货周转天数 (天)78.92884.420105.97177.74161.730